In 2026, the stock market continues to evolve and remains highly volatile, driven by global news, economic trends, and shifting investor sentiment. For traders, keeping up with these rapid market changes can be both exciting and overwhelming. Fortunately, AI stock trading bots are increasingly used to automate trading strategies and reduce emotional decision-making.

But do these AI-driven trading bots actually deliver on their promises? How effective are these tools in supporting trading performance under different market conditions? In this article, we’ll explore seven free AI stock trading bots in 2026, examining their features and how they may influence trading workflows and decision-making processes.

What Are AI Stock Trading Bots?

AI stock trading bots are automated software tools powered by artificial intelligence (AI) designed to assist in making decisions and executing trades in the stock market. These bots use algorithms to analyze data, identify trends, and trade based on the predefined strategies set by the user. For instance, they can buy a stock when its price drops or sell when it reaches a target.

Unlike human traders, AI bots are emotion-free, making decisions based on data and logic. This helps reduce common errors caused by emotional responses like fear or greed. These bots can operate continuously, which may reduce the likelihood of missing trading opportunities, even when you’re not actively monitoring the market.

Setting up a trading bot has become easier than ever, with many platforms offering customization options, strategy testing, and performance tracking. Different AI trading bots are designed to support varying levels of experience and trading requirements.

Overview of 7 Free AI Stock Trading Bots (2026)

Here are seven commonly used free AI stock trading bots in 2026, each offering different features for automation, analysis, and trade execution. These bots cater to both beginners and experienced traders with various features and strategies.

1. MoneyFlare – AI Trading Platform with Automated Execution

Key Strengths:

• Fully automated trading powered by machine learning.
• Offers a variety of preset strategies for different trading styles.
• Adjusts trading strategies based on market data and predefined parameters.

Do They Actually Work? 

MoneyFlare may be suitable for users seeking automated trading with minimal manual setup.

Users can visit the platform to review available account options and promotional offers.

2. TradeSanta – AI Trading Platform with Simplified Setup

Key Strengths:

• Simple interface with easy-to-configure preset strategies.
• Includes risk management features to safeguard trades.
• Offers integration with multiple stock exchanges.

Do They Actually Work? 

While performance depends on market conditions, TradeSanta is commonly used by traders seeking a simplified automation process.

3. 3Commas – Advanced Customization and Risk Management

Key Strengths:

• Highly customizable trading strategies, suitable for advanced traders.
• Robust risk management tools like trailing stops, take-profit, and stop-loss orders.
• Integrates with multiple exchanges for seamless trading.

Do They Actually Work? 

3Commas provides a range of advanced tools for strategy customization and risk management. It requires a bit more expertise, but it may offer additional flexibility for traders with more advanced requirements.

4. Pionex – Platform Supporting High-Frequency and Automated Trading

Key Strengths:

• 16+ free bots, including grid trading and DCA (Dollar-Cost Averaging).
• Built-in bots, meaning no need for external API connections.
• Low fees, making it ideal for frequent trading.

Do They Actually Work? 

Yes, Pionex offers effective bots that perform well in high-frequency, short-term trading. It may be suitable for active traders focused on short-term strategies.

5. Cryptohopper – AI + Copy Trading Hybrid

Key Strengths:

• Combines AI-driven trading with copy trading.
• Cloud-based, operating 24/7 for continuous trading.
• Customizable strategies for experienced traders.

Do They Actually Work? 

Yes, Cryptohopper allows new traders to copy successful strategies while benefiting from AI-driven insights. It may be useful for users interested in combining automation with strategy replication.

6. Trade Ideas – AI-Powered Stock Scanners and Alerts

Key Strengths:

• Real-time stock scanning powered by AI to identify trading opportunities.
• Predictive analytics for breakout and trend analysis.
• Backtesting feature for validating strategies on historical data.

Do They Actually Work?

Yes, Trade Ideas is great for active traders who want real-time, AI-assisted insights, but prefer to make the final decisions manually. It’s particularly useful for identifying stock trends and potential moves.

7. Wealthfront – AI Robo-Advisor for Long-Term Investing

Key Strengths:

• AI-powered portfolio management and asset allocation.
• Offers tax-loss harvesting and portfolio rebalancing features.
• Ideal for long-term, passive investing rather than day trading.

Do They Actually Work? 

Yes, Wealthfront is often used for long-term portfolio management and automated investing. It’s not for those seeking short-term trading but works well for steady, hands-off growth.

Do AI Stock Trading Bots Generate Consistent Returns?

The answer depends on multiple factors, but with caveats. AI stock trading bots may support trading efficiency, but outcomes vary based on strategy and market conditions., but their success depends on several factors:

1. Market Conditions: AI bots perform best in stable or trending markets. During extreme volatility or market crashes, they may struggle to deliver consistent results.
2. Customization: Some bots require you to fine-tune settings and strategies for optimal performance. If not properly configured, their performance could be suboptimal.
3. Risk Management: Even though AI bots can automate trading, you still need to implement proper risk management strategies to avoid significant losses.

What You Need to Know:

• Consistency: Bots may not perform consistently in all market conditions, so you should manage your expectations.
• Strategy and Monitoring: Success often requires active monitoring and tweaking of strategies. Bots alone cannot guarantee profits.
• Risk: No bot eliminates risk entirely. Always use appropriate risk controls, such as stop-loss orders.

Conclusion: Are Free AI Stock Trading Bots Worth It?

In 2026, free AI stock trading bots can be effective tools for automating your stock trading strategy. Whether you’re looking to trade on a hands-off basis or want to capitalize on data-driven trading, these bots provide tools that may support automated trading strategies. However, it’s important to choose the right bot for your specific needs, set up your strategies correctly, and always keep an eye on your trading performance.

By leveraging AI bots like MoneyFlare for automation or Trade Ideas for real-time alerts, traders can use data-driven insights to inform decision-making, similar to approaches seen in Best crypto trading bot tools. But remember, no bot guarantees success. The key to success lies in how you use the bot, manage your risks, and adapt to the market.

The post Overview of 7 Free AI Stock Trading Bots: Features and Performance (2026) appeared first on Ventureburn.

Elorian has raised $55 million in a seed funding round, reaching a $300 million valuation. The company said the raise strengthens its long-term research roadmap. It also signals strong early investor confidence in visual reasoning AI systems.

The round was co-led by Striker Ventures, Menlo Ventures, and Altimeter. NVIDIA joined the funding round too, teaming up with well-known AI researcher Jeff Dean. Their backing shows that big players are getting more interested in AI systems that actually interact with the real world.

The company plans to use the capital to expand operations and engineering capacity. It will also scale model training infrastructure to support more advanced visual reasoning systems. Hiring across research and product teams is expected to accelerate.

Elorian, based in Palo Alto, works as both an AI research group and a product lab. They’re all about building technology that can make sense of visual information on its own. Its approach moves beyond traditional image-to-text AI pipelines.

New AI Systems Focus on Native Visual Reasoning

Elorian is building AI models that process visual inputs without converting them into text first. Most current systems rely on text-based interpretation layers. Elorian removes that step to improve spatial and contextual understanding.

The company develops multimodal architectures that interpret physical structure and spatial relationships. These systems are designed to understand design intent and environmental constraints. This allows AI to move beyond simple image recognition tasks.

Elorian also enables direct interaction with visual representations. Its models can manipulate and reason about structured visual data. This approach treats images as dynamic environments rather than static inputs.

The company aims to close what it calls a reasoning gap. Many problems in engineering and robotics cannot be easily described using language. Visual reasoning allows AI to address these challenges directly.

Industrial Demand Drives Physical AI Adoption

Elorian’s visual reasoning AI enables smarter decision-making across industries by understanding dynamic environments before taking action. Source: Created by Ventureburn

Elorian is targeting industries where visual understanding is critical. These include robotics, aerospace, medicine, and manufacturing. Each of these sectors relies on real-world visual decision-making.

Traditional vision systems often fail in production environments. They perform well in controlled datasets but struggle in dynamic conditions. Changes in lighting, materials, or workflows can reduce accuracy significantly.

Elorian’s models aim to address these limitations. They evaluate context before making decisions rather than relying on pattern matching. This helps reduce errors in unpredictable environments. The company believes reasoning is more important than classification. 

It focuses on systems that understand environments before taking action. This approach is especially important for robotics applications. Investor interest in physical AI is rising rapidly. Companies want systems that operate reliably without constant supervision. This demand is reshaping AI investment priorities in 2026.

More News: Oricell Therapeutics Raises $110 Million to Advance Global Cell Therapy Development

Scaling Strategy and Future Model Deployment

Elorian plans to expand its research teams and computational infrastructure. The company will increase model training capacity to support more advanced systems. It also aims to strengthen early commercial relationships with industry partners.

The startup is currently in discussions with potential customers. These include firms in robotics and industrial automation. Early pilots are expected to test real-world system performance. Elorian has not yet generated revenue. However, it plans to release its first public reasoning model within 12 months. This will mark a key milestone in its development roadmap.

Testing will focus on real industrial environments. These include factories and robotics operations with unpredictable conditions. The goal is to validate performance beyond controlled benchmarks.

Physical AI is becoming a highly competitive sector. Multiple startups and major tech firms are investing heavily in the space. Elorian is positioning itself at the reasoning layer of this ecosystem. The company focuses on understanding before movement. 

This separates it from robotics firms focused only on motion and control. Elorian believes reasoning is the missing foundation of physical AI. Success will depend on real-world deployment results. Industrial environments will test the system’s reliability under pressure. The next 12 to 18 months will be critical for validation.

To stay updated on crypto venture capital funding and market trends, visit our venture capital news section for more insights.

The post Elorian Raises $55M to Scale Visual Reasoning AI appeared first on Ventureburn.

Oricell has raised $110 million in a major pre-IPO round. The company said the raise will speed up its global growth. It stressed that the funds would support clinical work across core assets. It also said the capital will reinforce its technical infrastructure. The company called the raise a milestone in its long-term plan. It said the financing shows strong confidence from investors in its work.

The round attracted a mix of global health investors. The company confirmed that new and existing backers joined the financing. It said this broad support would help it scale at a critical point. Investors highlighted the firm’s focus on high-impact cell therapies. They praised its progress in multiple clinical programmes. They also said its platform strength gave it long-term potential.

The company has shifted towards a wider global strategy. It said expansion into key markets is now a priority. It noted that cancer care still faces major gaps worldwide. It said its goal is to push new cell therapies to more patients. The company said global access remains central to its mission. It stressed that the raise would help it speed up regulatory and clinical work in major regions.

The firm said its plans include deeper work with hospitals and research partners. It aims to improve trial scale and pace. It noted that partnerships would support smoother global operations. It also said it would use part of the funds to grow its internal team. It wants to strengthen areas such as clinical design and manufacturing.

Lead Therapy Moves Toward Pivotal Trials

The company’s lead therapy is approaching a key stage. It has advanced through early clinical testing. It has shown strong signals in safety and effectiveness. Data from trials showed encouraging patient outcomes. The firm said these results support the move towards pivotal studies. It added that demand for new cancer treatments is high worldwide.

The lead programme focuses on liver cancer. The company said the disease still lacks effective treatment options. It noted that global cases continue to rise. It also said many patients face limited access to new therapies. The firm believes its lead therapy could reshape this space. It highlighted data presented at major medical meetings. It said this visibility reflects growing medical interest.

The therapy uses a targeted cell-based approach. It is designed to attack cancer cells more directly. Early trials showed strong control of tumour growth. They also showed a consistent safety pattern. The company said these results supported deeper global testing. It now plans to expand the therapy into more regions. It stressed that late-stage trial planning is already underway.

The firm also said it was expanding its manufacturing capability. It wants to support larger trial groups. It is investing in systems that speed up production. It said this would help meet future patient demand. It stressed that manufacturing remains a major barrier for the sector. The company believes its platform can remove some of these limits.

Technology Platforms Strengthen Pipeline Growth

Oricell’s integrated platform approach accelerates next-generation cell therapy development through innovation in discovery, performance, and production. Source: Created by Ventureburn

The company uses three core platforms to support its therapies. It said these tools improve the design and performance of new treatments. The first platform focuses on antibody discovery. The second strengthens T-cell function. The third improves manufacturing speed. The company said this combination sets it apart in the market. It noted that many firms rely on single-track development.

The company said its platforms help it build stronger therapies. They support better control, better activity and faster production. The platforms allow it to test and refine many candidates. The firm said this cuts development time. It stressed that these tools give it a long-term strategic advantage. It also said they support the creation of next-generation therapies.

The firm is expanding its research portfolio. It has more than one product moving through global studies. It is also testing new cell-based approaches. These include rapid-production models. They also include therapies designed to work inside the body. The company said these areas show strong promise. It added that global demand for solid tumour treatments remains high.

Investors said the company has built a strong “platform and pipeline” model. They also said it had shown steady progress over time. They praised its early clinical results. They also highlighted its strong global ambitions. The company said this feedback showed confidence in its direction. It added that it plans to push further into next-generation cell therapy.

More News: Sedron Technologies Raises $500M to Scale Waste-to-Resource Upcycling

Clinical Milestones Signal Future Expansion

The company has secured key global approvals to support its work. It said multiple regulatory bodies had cleared its programmes. It noted that global authorities had granted fast-track pathways. These approvals will help shorten development time. They also support broader access across regions.

The company said data from global trials had been encouraging. It said investigators had reported consistent performance. It highlighted strong signals of activity in trial groups. It also said safety had remained steady. The firm believes these results will support expansion into more markets. It plans to widen its work with regulators. It also aims to prepare for larger commercial steps.

The company said the funding marks a turning point. It said it can now scale both research and clinical delivery. It noted that cancer care needs major innovation. It believes new cell therapies can fill that gap. It said the raise gives it the strength to compete globally. It also said it will continue to invest in next-generation science.

To stay updated on crypto venture capital funding and market trends, visit our venture capital news section for more insights.

The post Oricell Therapeutics Raises $110 Million to Advance Global Cell Therapy Development appeared first on Ventureburn.

Cybersecurity veterans from top security companies, including Zscaler, Palo Alto Networks, and Netskope, established Aurascape. Its leadership explains that currently available web security solutions have not been architected to allow for the complex data flows that existing AI implementations require. Many AI systems have multiple signalling protocols and dynamic data exchanges that traditional security tools are generally unable to monitor or control. 

Existing security infrastructure built for general traffic will not be effective for protecting AI traffic. Aurascape wishes to build its security infrastructure for AI traffic for better visibility and the security of enterprises.

Rising Security Concerns Around AI Adoption

Organisations have significantly increased their use of AI since the introduction of generative AI tools like ChatGPT. Firms leverage AI for numerous activities, including content creation, software engineering and operational streamlining. But it has also posed issues for security. Workers are exploring and testing third-party AI applications without approvals from IT teams, so the phenomenon is what industry experts now refer to as “shadow AI”.

Source: Unsplash

Organisations are using unapproved AI tools, like Shadow AI, which could potentially leak critical company data. This includes storing and processing the data shared on the platform and possibly using it to train machine learning models. Aurascape hopes to address this issue by providing enterprise customers with visibility and security for interactions on their network against a web of things.

More News: MillTech Bags $60M to Scale Treasury and FX Tools

Aurascape’s AI-Native Security Platform

Aurascape is building an AI-native security platform for an AI-native era. Instead of using typical cybersecurity solutions like firewalls and proxies, the company had to develop an AI-native security system that could evaluate how workers were actually working with AI tools.

The platform monitors AI traffic and usage trends for thousands of apps. It can identify openings for data leaks or other malicious activity by following prompts, output, or any additional communication.

Aurascape analyses a wide range of content types: text, images, sound, video, and source code. Security teams can track AI activity, independent of the type of information employees are sharing over AI services.

A further important aspect of the platform is automated policy enforcement. Using it, firms can set policies limiting the access that their AI applications have to corporate data to prevent it from leaking to outside models.

A Growing Market for AI Security

Aurascape’s launch date coincides with a rush among cybersecurity companies to close off the opportunities for exploits posed by generative AI. Businesses feel forced to innovate and secure at the same time. AI has the potential to dramatically boost productivity but also provide cybercriminals with new avenues of attack and accidentally expose data.

Security platforms, such as Aurascape, seek to close this gap by making it easier for enterprises to adopt AI-powered solutions while still providing governance, control, and compliance. Ahead of the close of its recent Series A financing of $50 million, Aurascape will use the proceeds to speed up the development of its platform, grow its engineering team and deploy the platform to more enterprise customers.

The post Aurascape Raises $50M to Secure Enterprise AI Applications appeared first on Ventureburn.

A Strategic Pivot in Commercialization

Since 2020, Click and Boehringer Ingelheim have collaborated to bring CT-155 to market. In this new deal, Boehringer Ingelheim is ceding complete product responsibility (including all commercial and marketing authorization rights) to Click Therapeutics.

Source: Click Therapeutics 

This is a significant milestone for Click, which is transitioning from a pure R&D partner to an integrated commercial stage powerhouse. David Benshoof Klein, CEO and founder of Click Therapeutics, said:

“Boehringer Ingelheim’s choice of Click to deliver CT-155 to patients is an incredible validation of the vision we have spent ten years developing and our executional capabilities. We are ready now to step up and are laser-focused on getting this FDA-designated Breakthrough Device to patients.”

More News: MillTech Bags $60M to Scale Treasury and FX Tools

Breakthrough Data Driving the Investment

The Series D is following the completion of the Phase III CONVOKE study. The trial evaluated CT-155 as an add-on to antipsychotic drugs, which are standard treatment for schizophrenia. The results achieved will be historic, as this was the first pivotal trial of a digital therapeutic to demonstrate a statistically significant reduction in the experiential negative symptoms of schizophrenia (social withdrawal, apathy, and lack of motivation). 

Relative to a digital control group, the study experienced a 62% relative improvement in symptom severity at 16 weeks. The therapy was also tolerated well, and no app-related discontinuations occurred, whereas the usual drugs in this patient population are associated with a harsh side effect profile.

Strengthening a Dominant Pipeline

The investment of 50 million dollars shows a potential high-water mark for Click Therapeutics. In just 24 months, Click Therapeutics has gained several major milestones:

• Rejoyn™ (co-developed with Otsuka Pharmaceuticals) obtained an FDA authorization and became a digital treatment for Major Depressive Disorder (MDD).
• The FDA cleared a new digital therapeutic named CT-132 in 2025, for the preventive treatment of episodic migraine.
• Click partnered with Ultrahuman for wearable biomarkers for migraine and secured a Series C investment round with Medidata/Dassault Systèmes.

With rights and funding to acquire CT-155, cementing its role as the “operating system” for “Software Enhanced Drug™” therapies.

The Road Ahead

Although the digital therapeutics industry has been smooth sailing, Click’s platform-first approach shows they are the tactic to beat. If approved, the new drug will be the latest addition to Click’s portfolio that marries chemistry and behavioural software into treatment tools.

The post Click Therapeutics Secures $50M Series D Funding Deal appeared first on Ventureburn.

Sedron Technologies has raised $500 million to scale its advanced upcycling systems across North America. The company plans to use the investment to expand its manufacturing capacity. It also intends to accelerate deployment of its technology across major municipal and agricultural operations. The funding marks the largest commitment to its waste-to-resource systems to date. It supports a wider push to advance sustainable waste processing solutions.

The company was formed as a spin-off from a long-established engineering group. It focused on building technology that reduces the energy demands of traditional waste systems. Its core system, known as Varcor, separates liquid waste streams into purified water, nutrient-rich fertiliser, and other valuable outputs. The process requires far less energy than standard treatment methods. It also reduces the volume of material that ends up in disposal facilities.

Varcor technology is used in municipal and agricultural settings today. Each sector has a distinct model. Both rely on the same core process. The system recovers water and nutrients while providing outputs that support energy production or organic farming. The company sees strong demand in both sectors due to rising interest in sustainable resource recovery. It plans to build more facilities over the next few years.

Municipal Biosolids Upcycling Drives Cleaner Waste Management

The municipal sector is a major focus for Sedron Technologies. Its Varcor systems process wastewater biosolids into purified water. The system also produces a concentrated fuel used to generate carbon-negative electricity. This process destroys hard-to-remove contaminants. It tackles chemicals that often escape conventional treatment systems.

Municipalities in the United States face rising costs in biosolids disposal. They also face pressure to reduce pollutants such as PFAS. Sedron Technologies aims to support these goals. It has announced its plans for a new biosolids upcycling facility in Florida. The facility will serve several towns across the region. Construction is expected to begin this spring. The site is expected to start operations in 2028.

The company’s treatment process offers two major benefits. It reduces the cost of handling biosolids. It also improves water recovery and pollutant destruction. Local governments view these benefits as critical to long-term environmental protection. The company says interest in municipal deployment continues to grow. It expects wider adoption across the country.

Agriculture Upcycling Brings New Revenue Streams to Dairy Producers

Sedron Technologies’ Varcor system transforms dairy waste into purified water and certified organic fertilisers, reducing emissions and supporting sustainable farming practices. Source: Created by Ventureburn

Sedron Technologies also focuses on agriculture. Its Varcor system converts dairy manure into purified water, dry organic fertiliser, and a liquid organic ammonium nitrate fertiliser. These products support organic farming practices. They reduce nutrient runoff. They also lower methane emissions from traditional manure systems.

The liquid fertiliser produced through the Varcor process is certified for organic use. It gives organic farms access to a nitrogen fertiliser that is hard to source. Many organic farms struggle to secure plant-available nitrogen inputs. Sedron Technologies aims to close this gap. The company says demand for the fertiliser is rising.

The company currently operates a large agricultural upcycling project in Indiana. It processes manure from a 20,000-cow operation. The project converts waste into tens of thousands of tonnes of fertiliser each year. Another site in Wisconsin is being commissioned. It will support a 10,000-cow dairy. Commercial operations will begin this summer. The company expects more agricultural projects to follow.

For dairy producers, the benefits are clear. The technology lowers manure handling costs. It cuts methane emissions. It prevents soil phosphorus buildup. It also provides new revenue streams through the sale of organic fertiliser. These improvements support environmental goals. They also support the financial resilience of dairy producers.

More News: SiFive Raises $400 Million to Advance RISC-V Data Centre Chips

Funding Supports Manufacturing Growth and New Deployment Sites

The new $500 million investment will strengthen Sedron Technologies’ manufacturing operations. The company plans to expand production capacity. It also plans to accelerate deployment of new Varcor systems across North America. It aims to shorten project timelines and scale faster. The funding will support construction, engineering, and on-site deployment teams.

The company expects demand to increase over the next decade. Municipalities seek better ways to manage biosolids. Dairy farms seek alternatives to traditional manure systems. Both rely on resource-intensive processes. Sedron Technologies claims its systems reduce energy use significantly. The company sees these benefits as a key driver for long-term adoption.

Investors say the funding will help push the Varcor technology into more markets. They expect more projects to come online across the United States. They also expect stronger interest from international markets. The company has indicated plans to explore opportunities outside North America in the future.

A credible overview of sustainable waste-to-resource systems can be found here:
U.S. Environmental Protection Agency – Sustainable Resource Management.

The company says it remains focused on building systems that reduce waste and recover valuable resources. It plans to expand both its municipal and agricultural businesses. It also plans to push for broader adoption of low-energy waste processing systems. The funding is expected to support these goals over several years.

To stay updated on crypto venture capital funding and market trends, visit our venture capital news section for more insights.

The post Sedron Technologies Raises $500M to Scale Waste-to-Resource Upcycling appeared first on Ventureburn.

SiFive has raised $400 million in a major new round that pushes the company further into the centre of the data centre market. The round gives the firm a valuation of $3.65 billion. It also marks one of the largest single financings seen in the RISC-V ecosystem.

The team said the capital will accelerate development of its next wave of high-performance CPUs. These CPUs support advanced agentic AI workloads. They are designed for customers that want flexible, open-standard compute options. Demand has intensified as more hyperscale firms search for alternatives to legacy architectures.

Leadership said customers want customisable CPU blocks that increase performance without increasing power use. They also said customers want faster ways to bring new hardware to market. SiFive believes RISC-V offers a strong answer. The architecture supports scalar, vector, and matrix compute within one standard. That range is now essential for modern AI operations.

The company reached record growth in 2025. Its IP is now part of more than 500 chip designs. It has shipped more than ten billion cores. It expects this momentum to continue as AI workloads surge across data centre environments.

Focus on High-Performance CPU Development for Agentic AI

SiFive said rising demand for agentic AI systems is reshaping expectations for CPU performance. These systems require tight coordination across multiple compute layers. This is where CPUs outperform other accelerators. They manage workloads that GPUs alone cannot control efficiently.

The firm will use part of the new capital to expand its engineering teams. These teams will develop new generations of vector and matrix-enabled CPU IP. The roadmap also includes improvements in accelerator designs. The goal is to align with the long-term shift toward more autonomous AI systems.

The investment also deepens the firm’s collaboration with major partners. These partners are working to accelerate deployment of RISC-V in data centres. The company said it is enabling customers to adopt new architectures without a difficult learning curve. This includes software support. CUDA alternatives, Linux distributions, and other tools already run on its platform.

Analysts said the round signals a shift. The CPU is becoming central in data centre architecture again. They said chipmakers and cloud companies want alternatives that provide lower power use. They want greater design flexibility too. That combination is becoming essential as demand grows for new AI-driven compute systems.

RISC-V Adoption Expands Across Hyperscale and Cloud Markets

Rising RISC-V adoption is enabling flexible, energy-efficient AI systems as demand for scalable data centre performance continues to grow. Source: Created by Ventureburn

RISC-V adoption has increased rapidly over the past three years. Customers want control of their product designs. They want less dependence on fixed instruction sets. The open standard removes traditional limits. It also lets engineering teams build more efficient AI-capable systems.

SiFive said it now works with multiple large data centre companies. These companies want to diversify their processor base. They want options that reduce power use while scaling performance. The company said some of its high-performance products are already inside customer silicon today.

Analysts believe the market opportunity could exceed $100 billion over the coming years. Growth will be driven by AI adoption across enterprise and cloud settings. They said SiFive’s funding shows investors are preparing for the next stage of this shift. They also believe the company is well positioned to compete.

The data centre has become the fastest-growing market for new CPU designs. Companies want to avoid bottlenecks caused by older architectures. They also want better performance-per-watt ratios. This has created the right conditions for RISC-V adoption to accelerate.

More News: Collide Capital Secures $95M Fund II to Expand Early-Stage Investments

Plans and Path Toward a Potential Public Offering

SiFive said the round supports expansion across several areas. These include advanced R&D for CPU and accelerator IP. They also include software development. The company is working to strengthen data centre software pipelines that run on RISC-V. These pipelines help customers deploy new workloads without long delays.

The company is also improving support for enterprise customers. It helps them move from early testing to full deployment. It provides custom design help. It also provides support across power management and security layers. The goal is to build full IP solutions rather than individual CPU components.

Leadership said the company is preparing for long-term growth. It is also preparing for potential public offering readiness. There is no timeline. The current round provides enough capital to expand the roadmap. Leadership said they are focused on scaling high-performance products. They believe the agentic AI transition will create long-term demand.

Analysts said the size of the round shows investors are prepared to wait. They want to see how the data centre market evolves. They also said SiFive has moved from embedded products into the centre of the AI compute stack. This shift is rare and signals deeper confidence in the firm’s technology.

To stay updated on crypto venture capital funding and market trends, visit our venture capital news section for more insights.

The post SiFive Raises $400 Million to Advance RISC-V Data Centre Chips appeared first on Ventureburn.

Most notably, Generation Investment Management led the round with substantial investments from Fifth Down Capital and 8VC. Other already heavy investors, including Stripes, Addition, and Susa Ventures, also doubled down, showing a lot of faith in Chapter’s goal to reinvent retirement with AI.

Bridging the “Digital Gray” Gap

The tech industry has failed to cater to the 55-plus. For over 20 years, seniors had been forced to deal with cobweb-filled systems to access their Medicare and social security, yet the social media boom has been targeted at most other demographics. Not anymore, however, as Chapter founder and CEO Cobi Blumenfeld Gantz has a different venture in mind.

“Most technology companies ignore retirees,” said Blumenfeld Gantz in the announcement. “Our goal is to make sure that every senior is able to protect their health, wealth and identity by making the products we wish we had for our own parents when entering retirement.

Source: Chapter

Chapter’s most significant offering is an AI-native Medicare navigation platform. Whereas brokers may simply provide search results for 10–15% of available plans, Chapter’s proprietary algorithms analyze all 24,000+ plans nationwide and identify the best fit for the customer’s health needs and budget.

More News: MillTech Bags $60M to Scale Treasury and FX Tools

How AI is Revolutionizing Senior Care

The new investment arrives at a moment in which the era of “agentic AI” (artificial intelligence capable of undertaking complex tasks on its own accord) is emerging and transforming the professional services industry. Chapter leverages these innovations to offer an unprecedented level of “white-glove” service to the average investor.

By leveraging its AI platform, the company can:

• Spot benefits not considered: Discover secondary coverage or inexpensive prescriptions that human agents tend to overlook.
• Unbiased Advocacy: Because the platform is data-driven, the “commission bias” in the insurance industry no longer exists.
• Proactive Planning: Forecasting future healthcare costs, which can be based on present health trends, and assisting seniors to modify their saving strategy accordingly.

Expanding Beyond Medicare

Where the first Chapter focused on Medicare, the 100 million Series E will help build Chapter into a comprehensive retirement operating system. Upcoming plans include releasing other services such as life insurance, estate planning and senior-specific savings accounts.

Generation Investment Management’s partner Anthony Woolf pointed out that trust was Chapter’s key asset. “As our life world is reconfigured by artificial intelligence, Chapter is foresighted to help drive technologies forward for seniors’ benefit,” Woolf stated.

In the last year, the company has more than doubled its valuation, mirroring demand for “Silver Economy” technology. In the context of 10,000 baby boomers a day, Chapter’s AI-powered bridge looks set to be the most important infrastructure in American retirement.

The post Chapter Secures $100M to Bridge Seniors and AI Tech appeared first on Ventureburn.

MillTech offers a technology platform that enables corporations and investment managers with large cash flows to better manage FX hedging and cash management. Its technology automates all key FX lifecycle processes, from trade calculations and decision-making to execution, settlement and reporting.

A typical multi-bank FX risk management process involves a number of brokers and broken-down functions. MillTech offers a direct connection with its clients to the wholesale multi-bank market, a solution that offers better transparency and execution.

Pooling liquidity across multiple banking partners enables the platform to enable companies to hedge currency exposure with greater efficiency and less complexity. According to the company, its technology can lower FX execution costs by over 50% versus a traditional banking structure.

AI-Powered Treasury Tools

The funding focuses on developing artificial intelligence features within the platform. MillTech has been developing a suite of tools based on AI that ingest market data to provide optimised hedging strategies and enhanced risk management insights to clients, supporting improved decision-making on the timing and method of hedging currency exposure.

Source: Unsplash

As the harnessing of data and automation within financial institutions spreads, AI treasury solutions will become an integral part of the modern financial infrastructure. MillTech hopes to position itself as a cutting-edge platform for corporate treasury teams and institutional investors by incorporating the aforementioned technologies.

More News: Eclipse Ventures Raises $1.3B to Advance Physical AI Startups

Expanding Into North America

Another primary goal of the funding round is expansion into the United States and broader North American market. North America represents a major opportunity for FX risk management platforms because multinational companies in the region manage significant cross-border currency exposure.

According to MillTech CEO Eric Huttman, the new investment will help the company accelerate this growth strategy while continuing to build advanced treasury solutions. The partnership with Apax, he noted, validates the platform’s long-term potential and market demand.

Investors’ Confidence

The company’s investment is representative of a trend: the increase in demand for a high-tech way to handle the fluctuations in currency values. The global foreign exchange (FX) market sees an estimated 9.5 trillion dollars in daily currency trading, a number that accentuates the importance of FX risk management for companies.

MillTech has exhibited excellent momentum in the recent past. The company posted 79% revenue growth in 2024 and 73% in 2025, which is indicative of the swift uptake of its technology by institutional investors.

The platform processes $500 billion of trading each year, enabling institutional investors and corporate clients to hedge billions of dollars worth of currency exposure.

Apax Digital Funds, which led the investment, is already familiar with the platform. Apax has previously used MillTech’s technology across several of its funds to support investment operations, making the new deal both a strategic partnership and a financial investment.

The post MillTech Bags $60M to Scale Treasury and FX Tools appeared first on Ventureburn.

Collide Capital, an early-stage venture business organization, has fully concluded a shutdown on its Fund II worth $95 million. The firm is overcommitted with the fund signifying a quickened step from the original $66 million Firm 1 started up back in 2022.

Founded in 2021 by Brian Hollins and Aaron Samuels, Collide will invest in fintech, supply chain and future-of-work start-up companies with its second fund to write cheques at an early stage from $1m to $3m. Collide has already invested in five companies, including Art Lab, Jelou, Ocho, Prefix, and Sytrex.

“With over 75 companies in our portfolio and top quartile Total Value to Paid-In capital (TVPI) performance, Fund II allows us to deepen support for founders building enterprise software,” said Hollins. The firm aims to deploy the capital over the next 3.5 years and maintain its hands-on operational approach.

Collide’s strategy is distinguished by leveraging strong founder networks and providing access to Fortune 500 resources. The firm helps its portfolio companies gain cloud and compute credits, lines of credit, and introductions to procurement and revenue teams at leading corporations.

Collide Campus Expands Talent Development

Collide Capital is not only funding startups but also nurturing the next generation of venture talent through Collide Campus. The programme operates at more than 20 leading universities, including Harvard, Johns Hopkins, and Stanford.

Collide Campus offers undergraduates training in venture capital and entrepreneurship. MBA fellows gain real deal sourcing, diligence, and hands-on investment experience. Over 50 students have graduated from the programme, with alumni securing roles at Collide, General Catalyst, BEA Venture Fund, and other top firms.

“Collide Campus allows us to connect the most determined students with venture capital,” said Samuels. “It also helps source deals and talent while building a new generation of founders and investors.”

The firm has expanded the programme to include Breakthrough Ventures, an accelerator launched at Stanford University. Past participants have been accepted into Y Combinator, while others have become full-time employees at Collide. The initiative supports Collide’s mission to direct resources and opportunities toward the most deserving founders.

Portfolio and Sector Focus

Collide Capital supports high-growth startups with strategic funding and institutional backing, driving innovation across future-of-work sectors. Source: Created by Ventureburn

Collide invests from pre-seed to Series A stages. The firm applies a Gen-Z buyer lens for its future-of-work investments. This approach prioritises consumer and enterprise innovations in AI and automation.

The firm has backed notable companies such as Butter (acquired by GrubMarket), Coldcart, Culina Health, Helios, OneCarNow, Revi, Rheaply, Slang.ai, and Tandem. Its support includes operational guidance and access to investor networks, giving portfolio companies strategic advantages in early-stage growth.

Collide has made a name for itself as one of the few emerging firms scaling from proof-of-concept funds to institutional-grade platforms. The firm’s Fund Zero and Fund I have delivered top quartile returns, while its portfolio has seen five exits to date.

Limited partners in Fund II include the University of California Endowment (UC Regents), Accolade Partners, Fairview Capital, Goldman Sachs, and JPMorgan. This backing demonstrates strong investor confidence in the firm’s approach and long-term strategy.

More News: Court Square Capital Raises $3.8B to Expand Middle Market Investments

Plans and Market Position

Collide Capital plans to continue expanding Fund II investments across fintech, supply chain, and future-of-work sectors. The firm aims to support at least 30 startups and help them transition from early-stage to growth companies.

Hollins and Samuels bring extensive experience to the firm. Hollins invested at Goldman Sachs, Lightspeed, and Slow Ventures, and co-founded The Takeoff Institute. Samuels spent 15 years operating and investing at Blavity, Bain & Company, Lightspeed and Telesign as well as founding AfroTech. 

This knowledge provides the foundation of Collide’s hands-on support and ecosystem-building philosophy. The firm sets itself apart by providing potential entry into Fortune 500 companies, financing, and strategic partnerships. Collide combines investment with mentorship and operational suppost to make the founders and the overall ecosystem stronger.

Having closed its second fund, Collide Capital is now firmly established as a high-impact early-stage venture firm. It’s unique value proposition combining capital, networks and talent development provide a solid base from which to scale start-ups in new, emerging technology areas.

To stay updated on crypto venture capital funding and market trends, visit our venture capital news section for more insights.

The post Collide Capital Secures $95M Fund II to Expand Early-Stage Investments appeared first on Ventureburn.